Parkman Healthcare Partners LLC Opiant Pharmaceuticals, Inc. Transaction History

Parkman Healthcare Partners LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$9.38 - $20.29 $155,586 - $336,550	-16,587 Reduced 21.67%	59,943 $1.22 Million
Q3 2022 Nov 14, 2022	BUY	$9.52 - $13.48 $8,548 - $12,105	898 Added 1.19%	76,530 $823,000
Q2 2022 Aug 12, 2022	BUY	$10.12 - $23.32 $435,918 - $1 Million	43,075 Added 132.31%	75,632 $907,000
Q1 2022 May 13, 2022	BUY	$19.54 - $33.59 $24,737 - $42,524	1,266 Added 4.05%	32,557 $697,000
Q4 2021 Feb 11, 2022	BUY	$22.51 - $36.79 $29,060 - $47,495	1,291 Added 4.3%	31,291 $1.05 Million
Q3 2021 Nov 12, 2021	BUY	$13.28 - $25.79 $398,400 - $773,700	30,000 New	30,000 $772,000

300

Ticker OPNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,164,150
Description
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overd...

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Parkman Healthcare Partners LLC with notifications on news.